Form 4 for EOG EOG Resources
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0001127602-25-018706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-02 | 2025-06-30+ | EOG | Leitzell Jeffrey R. | EVP, COO | S - Sale+OE | $119.65 | -3,952 | 45.7K | -8% | -$472.9K |
| D | 2025-07-02 | 2025-06-30 | EOG | Leitzell Jeffrey R. | EVP, COO | F - Tax | $119.70 | -1,267 | 49.7K | -2% | -$151.7K |
| D | 2025-07-02 | 2025-06-30 | EOG | Leitzell Jeffrey R. | EVP, COO | D - Sale to Iss | $119.70 | -5,421 | 51.0K | -10% | -$648.9K |
| D | 2025-07-02 | 2025-06-30 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $75.09 | +8,640 | 56.4K | +18% | +$648.8K |
| D | 2025-07-02 | 2025-06-30 | EOG | Leitzell Jeffrey R. | EVP, COO | M - OptEx | $0.00 | -8,640 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-01 | S | D | 1 | $119.65 | 45,737.57 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-30 | S | D | 3,951 | $119.65 | 45,738.57 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-30 | F | D | 1,267 | $119.70 | 49,689.57 | D | — | — | |
| 4 | Common | Common Stock | 2025-06-30 | D | D | 5,421 | $119.70 | 50,956.57 | D | — | — | |
| 5 | Common | Common Stock | 2025-06-30 | M | A | 8,640 | $75.09 | 56,377.57 | D | — | — | |
| 6 | Derivative | Stock Appreciation Rights | 2025-06-30 | M | D | 8,640 | $0.00 | 0 | D | $75.09 · 2020-09-26 to 2026-09-26 | 8,640 Common Stock | (F1) The SARs granted became exercisable in increments of 33%, 33%, and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted became fully exercisable on September 26, 2022. |